v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 0 $ 27
Operating costs and expenses:    
Research and development 1,650 1,169
Selling, general and administrative 2,298 1,774
Total operating costs and expenses 3,948 2,943
Loss from operations (3,948) (2,916)
Other income (expense), net:    
Interest income and other income, net 169 69
Gain on change in fair value of warrant liability 1,223 181
Total other income (expense), net 1,392 250
Net loss from continuing operations (2,556) (2,666)
Net income from discontinued operations – See Note 3 0 73
Net loss $ (2,556) $ (2,593)
Net (loss) income per share attributable to stockholders:    
Basic and diluted, continuing operations (in dollars per share) $ (0.04) $ (0.1)
Basic and diluted, discontinued operations (in dollars per share) 0 0
Basic and diluted loss per share (in dollars per share) $ (0.04) $ (0.1)
Shares used in computing net loss per share of common stock, basic and diluted – See Note 9 (in shares) 69,821,593 26,268,209